NCT00297492

Brief Summary

This study tests whether stopping smoking by gradually cutting down first is more or less successful than stopping abruptly. We hypothesize that stopping by gradually cutting down first will produce more abstinence than stopping abruptly.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
750

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Jan 2006

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 24, 2006

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 28, 2006

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2008

Completed
4.6 years until next milestone

Results Posted

Study results publicly available

September 5, 2012

Completed
Last Updated

September 20, 2013

Status Verified

September 1, 2013

Enrollment Period

2.1 years

First QC Date

February 24, 2006

Results QC Date

May 31, 2012

Last Update Submit

September 17, 2013

Conditions

Keywords

Smoking CessationTobacco

Outcome Measures

Primary Outcomes (1)

  • Number of Participants With Prolonged Abstinence Through 6 Months Verified by Carbon Monoxide Measurement

    Number of participants with self-reported prolonged abstinence from cigarette smoking through 6 months of follow-up, verified by a breath carbon monoxide reading of less than 10 parts per million

    6 months

Study Arms (3)

Gradual reduction

EXPERIMENTAL

Intervention: Reduction Phone Counseling. Intervention: Pre-Quit Nicotine Lozenges. Intervention: Post-Quit Nicotine Lozenges.

Behavioral: Reduction Phone CounselingDrug: Pre-Quit Nicotine LozengesDrug: Post-Quit Nicotine Lozenges

Abrupt cessation

ACTIVE COMPARATOR

Intervention: Abrupt Phone Counseling. Intervention: Post-Quit Nicotine Lozenges.

Behavioral: Abrupt Phone CounselingDrug: Post-Quit Nicotine Lozenges

Minimal intervention

ACTIVE COMPARATOR

Intervention: Minimal Abrupt Phone Counseling. Intervention: Post-Quit Nicotine Lozenges.

Behavioral: Minimal Abrupt Phone CounselingDrug: Post-Quit Nicotine Lozenges

Interventions

Counseling of smokers to undergo gradual reduction in cigarettes per day prior to quit date. This includes 5 counseling calls: 3 calls focused on reduction prior to the quit date, 1 call two days prior to the quit date to discuss common strategies for preparing to quit, and 1 call two days after the quit date to discuss relapse prevention. Telephone counseling also discusses the proper use of nicotine lozenges during reduction and after the quit date.

Gradual reduction

Counseling of smokers to set a quit date and not change cigarettes per day prior to quit date. This includes 5 counseling calls: 1 to set a quit date, 1 two days prior to the quit date to discuss common strategies for preparing to quit, and 3 after the quit date to discuss relapse prevention. Telephone counseling also discusses the proper use of nicotine lozenges after the quit date.

Abrupt cessation

Minimal counseling to mimic intervention at a primary care office. This includes 2 counseling calls: 1 to set a quit date and 1 two days after the quit date to discuss relapse prevention. Telephone counseling also discusses the proper use of nicotine lozenges after the quit date.

Minimal intervention

2 mg lozenges for participants usually smoke their first cigarette more than 30 minutes after awaking. 4 mg lozenge for participants who usually smoke their first cigarette less than 30 minutes after awaking. Replace each forgone cigarette during reduction with one lozenge. Use additional lozenges to combat cravings to smoke.

Also known as: Commit Nicotine Lozenges
Gradual reduction

2 mg lozenges for participants usually smoke their first cigarette more than 30 minutes after awaking. 4 mg lozenge for participants who usually smoke their first cigarette less than 30 minutes after awaking. Replace each forgone cigarette while abstinent with one lozenge. Use additional lozenges to combat cravings to smoke.

Also known as: Commit Nicotine Lozenges
Abrupt cessationGradual reductionMinimal intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Interested in quitting gradually
  • At least 18 years old
  • Daily cigarette smoker
  • Smoke at least 15 cigarettes per day (CPD)
  • No change greater than 20% in CPD in the last month
  • Interested in quitting in next 30 days
  • Must agree to not use non-cigarette tobacco during study
  • No use of smoking cessation medication in last month
  • Have phone with voice mail
  • Willing to use nicotine lozenge
  • No other person in household in study
  • Fluent/literate in English

You may not qualify if:

  • Women who are pregnant or breastfeeding
  • Currently using medication for depression or asthma
  • Heart disease requiring medication
  • Heart attack in last month
  • Irregular heartbeat
  • High blood pressure not controlled by medication
  • Stomach ulcers
  • Diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Vermont Human Behavioral Pharmacology Lab

Burlington, Vermont, 05401, United States

Location

Related Publications (1)

  • Hughes JR, Solomon LJ, Livingston AE, Callas PW, Peters EN. A randomized, controlled trial of NRT-aided gradual vs. abrupt cessation in smokers actively trying to quit. Drug Alcohol Depend. 2010 Sep 1;111(1-2):105-13. doi: 10.1016/j.drugalcdep.2010.04.007. Epub 2010 May 26.

MeSH Terms

Conditions

Smoking Cessation

Condition Hierarchy (Ancestors)

Health BehaviorBehavior

Limitations and Caveats

Our projected incidence of abstinence was higher than what was actually observed, leading to lower statistical power than expected.

Results Point of Contact

Title
Dr. John Hughes
Organization
University of Vermont

Study Officials

  • John Hughes, MD

    University of Vermont

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Psychiatry

Study Record Dates

First Submitted

February 24, 2006

First Posted

February 28, 2006

Study Start

January 1, 2006

Primary Completion

February 1, 2008

Study Completion

February 1, 2008

Last Updated

September 20, 2013

Results First Posted

September 5, 2012

Record last verified: 2013-09

Locations